More than 135,000 women have filed lawsuits against manufacturers of pelvic mesh products and in public comments to the FDA scores of women have asked for a nationwide ban or recall of the devices. While the FDA decided not to impose an outright ban on the products, the manufacturers have been ordered to submit new safety and effetiveness data on pelvic organ prolapse surgeries by the summer of 2018. The FDA announced on January 3 that the devices will now carry a Class III warning indicating a high risk for adverse events. The device makers have defended their products in litigation, however, thousands of claims have been settled and the new rules make the future of mesh products uncertain. Showard Law Firm represents hundreds of women with mesh implants and has been settling claims since August 2014.